< Back to Article

Reduction of the CD16⁻CD56^bright NK Cell Subset Precedes NK Cell Dysfunction in Prostate Cancer

Table 5

Comparisons of NK activity and the CD56^dim-to-CD56^bright ratio between controls and patients grouped according to clinicopathological variables.

doi: https://doi.org/10.1371/journal.pone.0078049.t005